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Summary
Objectives: Ank encodes a transmembrane protein that is involved in pyrophosphate (PPi) transport and mutations in the Ank gene have
been associated with pathological mineralization in cartilage and bone. To understand how Ank works in normal skeletal development it is
also important to know which cells within the developing skeleton express Ank. To this end, we examined the expression pattern of Ank
mRNA during mouse embryonic development as well as in mouse hind limb joints with emphasis on the period when articular cartilage forms.
Since it was previously shown that TGF- regulates PPi transport in cells in culture, we also tested the hypothesis that TGF- regulates Ank
expression.
Methods: The localization of Ank mRNA was determined by radioactive in situ hybridization in E15.5 and E17.5 mouse embryos as well as
in 1 and 3 week post-natal mice. Ank expression was compared to that of other cartilage markers. In situ hybridization and semi-quantitative
RT-PCR were used to determine the effects of TGF- on Ank expression in metatarsal organ cultures.
Results: Ank expression was detected at high levels at sites of both endochondral and intramembranous bone development. In
endochondral bones, expression was detected in a subset of hypertrophic cells at ossification centers. Expression was also detected in
osteogenic/chondrogenic cells of the perichondrium/periosteum lining the metaphysis, an area associated with the formation and extension
of the bone collar. High levels of expression were also detected in non-mineralized tissues of the skeletal system including tendons and the
superficial layer of the articular cartilage. Treatment with TGF- resulted in an approximately four-fold induction of Ank mRNA in
prehypertrophic chondrocytes and perichondrium of metatarsal cultures.
Conclusions: The expression pattern of Ank suggests an important role both in inhibiting and regulating mineralization in the developing
skeletal system. In addition, TGF-1 is able to mediate Ank mRNA expression in chondrocytes suggesting a possible role for TGF- and Ank
in the regulation of normal mineralization. © 2002 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights
reserved.
Key words: Ank, Transforming growth factor-beta, Pyrophosphate, Mineralization.Received 7 November 2001; accepted 23 January 2002.
Address correspondence to: Rosa Serra, Department of
Molecular and Cellular Physiology, University of Cincinnati, School
of Medicine, Cincinnati, OH 45267-0576, U.S.A. Tel: (513) 558-
4626; Fax: (513) 558-5738; E-mail: serrar@ucmail.uc.eduIntroduction
Bones of the vertebrate skeleton are formed by either
intramembranous or endochondral ossification (reviewed in
Ref. 1). During intramembranous ossification mesenchymal
cells differentiate directly into preosteoblasts and osteo-
blasts. Mineralization of the matrix follows, first in an
irregular pattern leading to the formation of woven bone
which is subsequently remodeled and replaced with lamel-
lar bone. Bones formed by intramembranous ossification
include the flat bones of the head and the clavicle. Most of
the bones in the body, including the long bones of the
appendicular skeleton form by the process of endochondral
ossification. Endochondral bones are derived form a carti-
lage model1–3. During embryonic development mesenchy-
mal cells condense and differentiate into chondroblasts
forming the initial shape of the skeletal element. Cells then
undergo a complex program of proliferation, differentiation,
and hypertrophy resulting in a matrix that can be mineral-
ized and replaced with bone. Recapitulation of this process482in the growth plate allows for longitudinal growth of bones
after birth. After the initial shape of the skeletal element is
formed, cells from the perichondrium (which at this point
becomes the periosteum) at the center of the element
differentiate to form a bone collar4. The bone collar marks
the ossification center of the bones and precedes vascular
invasion and mineralization of the cartilage. Formation and
extension of the bone collar can be regarded as intramem-
branous ossification. Appositional growth of the bone also
occurs from the perichondrium/periosteum.
Although most of the cartilage model will be replaced
with bone there are several sites where mature cartilage
persists throughout life, for example the articular cartilage
on joint surfaces. The formation of the articular cartilage in
mouse is similar to that described for human5, rabbit6, and
opossum7. The femoral and tibial epiphysis of the newborn
mouse are composed entirely of cartilage. At 7–10 days
after birth, a secondary ossification center forms in the
epiphysis, delineating the epiphyseal growth plate cartilage
from the future articular cartilage. By 2 weeks of age, the
articular cartilage begins to show some of the organiza-
tional characteristics of adult articular cartilage; however,
endochondral bone formation still occurs in the deepest
layers of the cartilage next to the ossification center. At 3
weeks of age, only a few hypertrophic cells are still visible
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PCR CLONING ANK INTO PBLUESCRIPT VECTOR
Ank was cloned into the pGEM-T easy vector using the
TA cloning kit from Promega. Ank cDNA was amplified from
cDNA made from mouse brain RNA using the following
primers: AnkR CAGGAATTTAGTGAACTGTGTCC and
AnkF ACAGAGGAGGTCACAGACATC amplifying nucleo-
tides 1462 to 2593 of the Ank gene (GenBank AF274752;9).
The identity of the clone was verified by sequencing. In
addition, two bands of the expected size (9; 3.5 and 4.0 Kb)were observed in Northerns blots of RNA from epiphyseal
cartilage (data not shown)IN SITU HYBRIDIZATION
In situ hybridization of mouse skeletal tissue has been
described14,19. Joints from at least three separate mice
were studied and representative images from one mouse
are shown. The following probes were used in this study:
ank (described above); collagen type IIA (pSOK10;20);
collagen type IIB (pEL111;21); collagen type X
(pSAm10h;22); decorin (pmDcncDNA ex2 to ex7; gift from
Dr Vogel, University of Ulm, Germany;23).METATARSAL CULTURE
Metatarsal culture and treatment with TGF-1 has been
described15,16.RT-PCR
RNA isolation and RT-PCR analysis have been
described in16. Primers used for Ank are described above.
Primers for glyceraldehyde-3-phosphate dehydrogenase
were: 3′ CAT GTA GGC CAT GAG GTC CAC CAC; 5′ TGA
AGG TCG GTG TGA ACG GAT TTG GC.ResultsEXPRESSION PATTERN OF ANK MRNA IN MOUSE EMBRYOS
To begin to understand how Ank regulates normal skel-
etal development, the expression pattern of Ank mRNA
during mouse embryonic development was determined
using radioactive in situ hybridization. Sagittal sections
from mouse embryos at 15.5 and 17.5 days of gestation
were hybridized to an 35S-labeled Ank riboprobe. The
highest levels of Ank mRNA were detected spatially and
temporally at known sites of bone development and miner-
alization (Fig. 1). These sites included both developing
intramembranous and endochondral bones.
In the head [Fig. 1(a),(b)], hybridization to the Ank
riboprobe was detected in the mandible, maxilla, and
frontal bone (intramembranous) as well as ossification
centers of the basioccipital and basisphenoid bones (endo-
chondral). Hybridization was detected in the clavicle,
another intramembranous type bone. Within the intramem-
branous bones, Ank mRNA was localized to mesenchymal
cells within the condensation of the bone anlagen.
Ank mRNA was detected in ossification centers long of
bones including the humerus, tibia, fibula, and femur which
are shown in Fig. 1(a),(c). Ank mRNA was not observed in
metatarsal bones at 15.5 days of gestation before the
formation of the ossification center. By embryonic day 17.5,
Ank mRNA was visible in hypertrophic chondrocytes at the
site of the newly formed ossification center [Fig. 1(d)]. In
bones in which the ossification center was more developed,
Ank mRNA was detected in cells lining the inner layer of the
perichondrium/periosteum at the diaphysis near the hyper-
trophic zone of cartilage [Fig. 1(c)]. This is an area where
the bone collar is forming to extend the central part of the
ossification center. In addition, hypertrophic chondrocytes
next to these ossification centers expressed Ank mRNA
[Fig. 1(c)]. Similarly, in the ribs, positive cells were lined upin the deep zones of the articular cartilage as the formation
of the bone and marrow cavity in the epiphysis nears
completion. After 4 weeks of age three main zones of adult
articular cartilage are visible and there is a sharp demarca-
tion between the cartilage and the subchondral bone.
Surprisingly little is known about factors that prevent articu-
lar cartilage from becoming mineralized and replaced with
bone.
Progressive ankylosis in mouse (ank/ank) is an auto-
somal recessive form of joint destruction characterized by
pathological mineralization in the articular surfaces and
synovium8. The Ank locus was recently shown to encode a
multipass transmembrane protein, called Ank, that regu-
lates pyrophosphate (PPi) transport9. Expression of Ank in
cultured cells resulted in increased elaboration of extra-
cellular PPi that was blocked by the addition of probenecid,
an inhibitor of anion transport9. Available data is consistent
with the possibiltiy that Ank may act a regulator of an anion
channel rather than exist as the channel itself (reviewed in
Ref. 10;9). PPi has been recognized as a direct and potent
inhibitor of mineralization in connective tissue matrix
(reviewed in Ref. 10). Articular cartilage and other non-
mineralized skeletal tissues including the meniscus have a
high level of extracellular PPi relative to mineralized tissues
so it has been proposed that Ank acts to prevent mineral-
ization of articular cartilage by regulating the level of PPi in
the matrix9,10. Ank mRNA has been detected by non-
radioactive in situ hybridization in cells at the articular
surface in forelimbs of mouse embryos at 16 days of
gestation9. Localization of Ank mRNA in other develop-
ing bones or in the post-natal period when the articular
cartilage forms was not reported.
Members of the TGF- superfamily are secreted signal-
ing proteins that regulate many aspects of development
including growth, differentiation, and mineralization in skel-
etal tissue11–13. Transgenic mice expressing a dominant-
negative mutation of the TGF- type II receptor develop an
osteoarthritis (OA)-like syndrome that includes progressive
loss of joint mobility, cartilage and bone growth in the joint
space an synovium, and formation of osteophytes on the
joint surface suggesting a role for TGF- in formation
and maintenance of the articular cartilage14. Furthermore,
mineralization is inhibited by TGF-1 in embryonic meta-
tarsal bones grown in organ culture15,16. TGF- has been
shown to stimulate PPi elaboration from articular chondro-
cytes in culture17. This effect was blocked by probenecid
suggesting that TGF- acted through an anion trans-
porter18. It is therefore possible that TGF- may at least in
part regulate mineralization through the regulator of PPi
transport, Ank. In this report we characterize the expression
pattern of Ank in embryonic and post-natal skeletal devel-
opment and test the hypothesis that TGF- regulates Ank
mRNA expression in chondrocytes.
484 P. Sohn et al.: Ank mRNA in cartilage and boneFig. 1. Ank expression during embryonic development. Sagittal sections from 15.5 day (a),(b) and 17.5 day (c),(d) mouse embryos were
hybridized to 35S-labeled antisense riboprobe for Ank. Bright field and dark field images are shown in (a) and (b). Hybridization is seen as
bright grains in the dark field image. In (c) and (d) the bright field image was inverted and superimposed on the bright field image using
photoshop software. Hybridization is seen as black grains on the image. Hybridization at skeletal sites is denoted with a small white arrow
in (a′) and (b′). Hybridization to non-skeletal sites is marked with a white arrowhead. Black arrowheads denote positive hypertrophic cells in
the 17.5 day metatarsal (c) and femur (d). Positive cells lining the inner layer of the perichondrium are marked with black arrows in (d).
Hybridization was not detected to a nonsense riboprobe (data not shown). bo, basioccipital bone; bs basisphenoid bone; cl, clavicle; fb,
frontal bone; hu, humerus; md, mandible; mt, metatarsal; mx, maxilla; of olfactory epithelium; ol, olfactory lobe; ri, rib; sg, serous gland; ti,
tibia; vf vibrissae follicle. Scale bar A, 1.4 mm; B, 1.0 mm; C, 100 m, D, 50 m.
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areas corresponding to the location of bone collar formation
near sections of histologically hypertrophic cartilage [Fig.
1(a)]. Ank mRNA was also detected in stromal fibroblast
invading the future marrow cavity [Fig. 1(c)].
Ank was not restricted to skeletal tissues [Fig. 1(a),(b)].
For example, hybridization was observed in vibrissae fol-
licles, the future cerebral cortex, olfactory epithelium and
associated serous glands, and cells within the olfactory
lobe in the brain.Fig. 2. Ank mRNA localization at 1week. Sections of tibia from 1-week-old mice were hybridized to the indicated 35S-labeled riboprobes.
Bright field and dark field images are shown. Hybridization is detected as white grains on the dark field image. Ank mRNA was detected in
the secondary ossification center [(a′), white arrowhead], the superficial layer of cells of the future articular cartilage [(a′), white arrow], cells
of the inner perichondrium [(a) black arrow] and in the tendon [(a), T]. Hybridization to the Collagen type X probe was detected in hypertrophic
cartilage (HC) of the secondary ossification center [(b′), white arrow head] and growth plate [(b), brackets]. Collagen type IIBm RNA was
detected in all cartilage except hypertrophic cartilage (HC) in the secondary ossification center [(c′), white arrowhead] and in the growth plate
[(c), brackets]. Hybridization was not detected to a sense Collagen type X probe (not shown). Scale bar=250 m.EXPRESSION PATTERN OF ANK MRNA IN POST-NATAL BONE
DEVELOPMENT
Since mutations in Ank result in joint destruction9, we
next focused our investigation on Ank expression during
normal articular cartilage development. Ank mRNA was
localized in tibia from 1- and 3-week post-natal mice in
relation to several cartilage markers (Fig. 2; see Fig. 4). In
1 week post-natal mice, Ank mRNA was localized to
hypertrophic cells near the secondary ossification center
486 P. Sohn et al.: Ank mRNA in cartilage and boneFig. 3. Ank mRNA localization at 1 week, high magnification.
Sections from 1 week hind limb joints were hybridized to a
35S-labeled riboprobe to Ank. Phase contrast pictures are
shown. Hybridization is seen as dark grains over specific cells. (a)
Hybridization to Ank riboprobe in hypertrophic cells near the
secondary ossification center (OC). Cells proximal to the ossifica-
tion center express higher levels of Ank (black arrows) relative to
hypertrophic cells that are more distal (white arrow). (b) An area of
the perichondrium at the junction of the growth plate and trabecular
bone of is shown. Ank mRNA is localized to cells within the
osteogenic/chondrogenic layer of the perichondrium (O/CL) but is
not detected in the fibrous layer (FL). Expression is also detected
in cells in the osteoid layer underlying the periosteum (arrowhead)
as well as hypertrophic cells at the transition between the growth
plate and trabecular bone (white arrows). Marrow cavity (M),
trabecular bone (B). (c) Ank expression in the superficial cells (SL)
of the future articular cartilage. Scale bar=25 m.[Fig. 2(a), arrowhead]; Fig. 3(a) as well as hypertrophic
cells at the transition of the growth plate and trabecular
bone [Figs 2(a), 3(b)]. Ank mRNA was also detected in
osteocytes embedded within the trabecular bone matrix
near the end of the growth plate [Fig. 2(a)]. Ank mRNA was
not detected in cells lining the trabecular bone. Collagen
type X is a marker for hypertrophic cartilage and is not
normally detected in articular cartilage from adult mice22.
Collagen type X was detected in the area of the secondaryossification center, where hypertrophic differentiation
occurs [Fig. 2(b), arrowhead] and in hypertrophic chondro-
cytes of the growth plate [Fig. 2(b), brackets]. The Ank
expression domain overlapped with only a small part of the
Collagen type X domain. Only a subset of histologically
hypertrophic cells in the secondary ossification center and
in the deepest layers of the growth plate expressed Ank
mRNA [Figs 2; 3(a),(b)]. Collagen type IIB is specific for
cartilage and is its major collagen species24. Collagen type
IIB was excluded from the secondary ossification center
where Collagen type X and Ank were observed [Fig. 2(c),
arrowhead].
In hindlimb joints from 3-week post-natal mice, Ank
mRNA continued to be detected in a subset of hypertrophic
cells at the transition between the articular cartilage and the
secondary ossification center [Fig. 4(a)]. Collagen type X
was still detected in this deep level of the developing
articular cartilage [Fig. 4(b)], presumably from normal
development occurring in the secondary ossification center.
Again, the expression domain of Collagen type IIB and
Ank did not overlap [Fig. 4(c)]. At this age, the formation of
the secondary ossification center is almost complete,
demarcating the separation of the articular cartilage from
the rest of the bone. Fewer cells at the edge of the
ossification center expressed Ank or Type X collagen
than at 1 week post-partum when differentiation and
mineralization occur rapidly.
Ank mRNA was localized to the osteogenic/
chondrogenic layer of the periosteum/perichondrium lining
the metaphysis at the junction of the growth plate and the
trabecular bone in mice at 1 week and 3 weeks post-partum
[Figs 2(a), 3(b), and 4(a)]. In addition, osteoblasts within
the osteoid that were lined up along the periosteum
expressed Ank mRNA [Figs 2(a), 3(b) and 4(a)]. This is an
area where appositional growth occurs and cortical bone
will form to extend the bone collar that was formed earlier in
development. Ank mRNA was excluded from or was
expressed at very low levels in the cortical bone itself and
the periosteum of the diaphysis.
Ank was also expressed in skeletal tissues that do not
undergo mineralization. High levels of Ank were detected in
tendon cells [Fig. 2(a)] and, as previously reported for
embryonic joints9, Ank mRNA was observed in the super-
ficial layer of the articular cartilage [Fig. 2(a), arrow; Figs
3(c) and 4(a)]. Articular cartilage remains unmineralized
throughout life and it was proposed that Ank expression in
the superficial layer of the articular cartilage and the result-
ing levels of PPi in the matrix prevent mineralization. The
expression pattern of Ank suggests that the gene product
Osteoarthritis and Cartilage Vol. 10, No. 6 487Fig. 4. Ank mRNA localization at 3 weeks. Sections of hindlimb joints from 3-week-old mice were hybridized to 35S-labeled riboprobes for Ank
(a), Collagen type X (b), and Collagen type IIB (c). Bright field and dark field images are shown. Hybridization is detected as bright white
grains on the dark field image. Hypertrophic cells between articular cartilage and subchondral bone are indicated by arrowheads. Expression
of Ank in the superficial zone of the articular cartilage is indicated by an arrow. Hybridization was not detected to a sense type X collagen
probe (not shown). Scale bar=250 m.may have a role in both preventing mineralization in
non-mineralized skeletal tissue and in regulating normal
mineralization at other skeletal sites.that TGF- regulates expression of Ank in metatarsal
bones grown in organ culture. Metatarsal bones from 15.5
day old mouse embryos were isolated and grown in a
chemically defined medium. Cultures were either treated
with 10 ng TGF-1/ml or left untreated for 5 days.
Previously, it was shown that treatment with TGF-1 inhib-
its mineralization in the cultures through a signaling
pathway distinct from those that regulate growth andREGULATION OF ANK MRNA EXPRESSION BY TGF-
Since it was previously shown that TGF- regulates PPi
transport in cells in culture17,18, we tested the hypothesis
488 P. Sohn et al.: Ank mRNA in cartilage and bonehypertrophic differentiation15,16. Ank expression was deter-
mined by in situ hybridization of sections from untreated
bones and bones treated with TGF-1 [Fig. 5(a),(b)]. In
control cultures, Ank was localized to a subset of hyper-
trophic cells the center of the bone rudiment where miner-
alization occurs; similar to what is seen in vivo. In TGF-1
treated cultures, Ank mRNA was localized to both pre-
hypertrophic and hypertrophic cartilages as well as the
perichondrium, suggesting that TGF- is sufficient to stimu-
late expression of Ank in chondrocytes and other cell types.
The level of Ank induction was determined using semi-
quantitative RT-PCR [Fig. 5(c)]. Ank and glyceraldehyde-3-
phosphate dehydrogenase (Gapdh) were amplified from
cDNA made from RNA extracted from bones that were
either untreated or treated with TGF-1 for 5 days. Gapdh
was used to control for the amount and quality of RNA used
in each reaction. PCR amplification was performed for avarying number of cycles to determine the linear range for
PCR product formation. Ank product formation was linear at
25 and 30 cycles and Gapdh was linear at 20 cycles. PCR
products were blotted to nylon membranes and hybridized
to radioactively labeled Ank and Gapdh probes. Band
intensity was quantified using a phosporimager. Ank results
were normalized to that for Gapdh. The experiment was
repeated three times with three separate sets of cultures
each with approximately 36 bone rudiments for each con-
dition. Treatment with TGF-1 resulted in a mean 3.64-fold
increase in Ank mRNA levels relative to untreated controls
(standard deviation=0.2-fold; T-test P value=0.000014)
indicating that TGF- can regulate Ank expression in
skeletal tissue.Discussion
The expression pattern of Ank is consistent with the
finding that mutations in Ank can affect both endochondral
and intramembranous bones. Recently, autosomal domi-
nant craniometaphyseal dysplasia (CMD) was shown to be
associated with mutations in the human ortholog to the
mouse Ank gene25,26. CMD is characterized by overgrowth
and increased mineral density of craniofacial bones as well
as abnormal, flared metaphyses (MIM 123000). In the
mouse, Ank mRNA was detected in mesenchymal cells of
intramembranous bone anlagen during embryonic develop-
ment. Furthermore, localization of Ank mRNA in hyper-
trophic cartilage and in the metaphysis where bone collar
extension and appositional growth occur is consistent with
the flaring observed in CMD.
In contrast to CMD, a nonsense mutation in murine Ank
results in an autosomal recessive condition known as
progressive ankylosis (ank/ank). Mice with the ank/ank
mutation demonstrate many features of arthritis including
ectopic calcification in the joints, cartilage erosion and
osteophyte formation, as well as fusion of the vertebrae27.
Synthesis of Ank in the superficial layer of the articular
cartilage may account for this phenotype since Ank acts to
regulate PPi transport and it has been shown that PPi can
inhibit mineralization in articular cartilage9,10. Abnormalities
in craniofacial bones or metaphyses have not been
described in the ank/ank mice. It was proposed that the
mutations isolated from CMD patients code for either
dominant-negative26 or gain of function25 mutations as
opposed to ablation of Ank expression as observed for the
mouse mutation9. The phenotypes associated with these
mutations and the localization of Ank at sites of mineraliz-
ation and at skeletal sites that remain unmineralized sug-
gest that the precise level of extracellular PPi must be
maintained for proper skeletal development. It has been
shown that both reduced levels of PPi and excess accumu-
lation of PPi result in pathological mineralization associated
with basic calcium phosphate or calcium pyrophosphate
dihydrate crystals respectively10,28.
Numerous mediators of bone mineralization have also
been shown to mediate the generation of PPi10. TGF-
was shown to regulate the generation of extracellular
PPi in chondrocyte cultures in a probenecid sensitive
manner17,18 and recently it was shown that generation of
PPi by Ank is also probenecid sensitive9. Here we show
that TGF- stimulates Ank expression in chondrocytes in
organ culture. TGF--mediated regulation of Ank may
account for the probenecid sensitive accumulation of PPi
previously observed in response to TGF-18. TGF- has
also been shown to regulate PC-1, a member of theFig. 5. TGF- mediated expression of Ank. Sections from
untreated (A) and TGF-1 treated (10 ng/ml; B) embryonic mouse
metatarsal bones grown in organ culture were hybridized to a
35S-labeled Ank riboprobe. Phase contrast and dark field images
are shown. Hybridization is detected as white grains on the dark
field image. In untreated cultures, Ank is detected in a subset of
hypertrophic chondrocytes in the center of the bone rudiment (a).
In treated cultures, Ank is detected in prehypertrophic and hyper-
trophic cells as well as cells in the perichondrium (b). Scale
bar=50 m. (C) RT-PCR. The level of Ank mRNA induced by
treatment with TGF-1 was determined using semiquantitative
RT-PCR. Embryonic metatarsal bones in cultures were either left
untreated (−) or treated (+) with TGF-1 for 5 days. Ank and
Gapdh were amplified for varying cycles. PCR products at 15, 20,
25, and 30 cycles are shown. PCR products were blotted to a
nylon membrane and hybridized to 32P-labeled cDNA probes for
Ank and Gapdh. Blots were exposed to a Molecular Dynamics
Phosporimager screen an band intensities were quantified. The
experiment was repeated three times with three separate sets of
cultures.
Osteoarthritis and Cartilage Vol. 10, No. 6 489phosphodiesterase nucleotide pyrophosphate family that
generates PPi directly by pyrophosphohydrolysis of the
phosphodiesterase I bond in purine and pyrimidine nucle-
oside triphosphates29,30. PC-1 deficient mice have what is
called the ‘tiptoe walking’ phenotype which shares some
similarities with the hypermineralization phenotype
observed in the ank/ank mice31. PC-1 is expressed at
overlapping and non-overlapping sites with Ank10. PC-1 is
expressed in chondrocytes within the articular cartilage and
in hypertrophic chondrocytes in the calcifying zone of the
growth plate. PC-1 is also expressed in osteoblasts and
osteocytes as well as in articular and periarticular liga-
ments. All three TGF- isoforms are widely expressed in
skeletal tissues19,32–34 and expression overlaps signifi-
cantly with Ank and PC-1 raising the possibility that
TGF- can regulate the expression or function of these
genes in vivo.
Previously we generated transgenic mice that express a
dominant-negative mutation of the TGF- type II receptor
(DNIIR) in articular cartilage, fibrous layers of the
periosteum/perichondrium, synovium, and a subset of cells
in the hypertrophic cartilage of the growth plate. DNIIR
mice demonstrate a joint phenotype strikingly similar to
that of the ank/ank mouse14 including progressive loss of
mobility in the joints, bone and cartilage growth in the joint
space, osteophyte formation and fusion of the vertebrae.
Expression of the DNIIR transgene overlaps with Ank
expression only in the superficial layer of the articular
cartilage and we were not able to detect any significant
alterations in Ank expression in these cells using radio-
active in situ hybridization (data not shown). It is possible
that in addition to regulating expression of Ank mRNA,
TGF- modulates the activity of Ank via post-translational
mechanisms. Alternatively, the similarities in the phenotype
may be due to alterations in the expressions of other genes
associated with cartilage differentiation or mineralization
that do not interact directly with Ank.
We and others have shown that TGF-1 can regulate
mineralization in embryonic metatarsal organ cultures15,16.
It was proposed that inhibition of mineralization was inde-
pendent of TGF-’s effects on growth and hypertrophic
differentiation15. The effects on mineralization were inde-
pendent of PTHrP while the effects on hypertrophic differ-
entiation were dependent on the presence of PTHrP16.
PTHrP 1-173 has been shown to inhibit the elaboration of
extracellular PPi in both costal and articular chondro-
cytes35,36. Regulation of extracellular PPi was controlled by
the 147–150 KKKK motiff which was also shown to regulate
nuclear localization36. Ank mRNA was localized only to a
subset of hypertrophic cells in the center of untreated
metatarsal cultures. In the presence of TGF-1, Ank mRNA
was detected in prehypertrophic chondrocytes and in the
perichondrium. In the metatarsal culture experiments (Fig.
5), Ank was induced almost four-fold after treatment with
TGF-1. It is interesting to speculate about a connection
between increases in PPi that would result from higher
levels of Ank synthesis and inhibition of mineralization
mediated by TGF-1 in this system.
In summary, we have shown that Ank mRNA is
expressed in the skeletal system in a pattern that suggest
that it regulates development of both mineralized and
non-mineralized skeletal tissue. We show that TGF- can
stimulate expression of Ank mRNA and suggest a testable
model where TGF- and Ank act together to regulate
mineralization.Acknowledgments
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